Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“We also have an agreement with Incyte under which we are entitled to manufacture a portion of Incyte's global commercial supply of retifanlimab (Incyte Commercial Supply Agreement).”
FILING10-K0001125345-26-000017cik 0001125345disclosed by MGNX
“Pursuant to our collaboration agreement with Incyte, we had exclusively licensed to Incyte monospecific antibodies targeting GITR, OX40, TIM-3 and LAG-3, as well as an additional undisclosed target.”
FILING10-K0001193125-26-108632cik 0001098972disclosed by AGEN
“For example, we received capital in connection with the exclusive option agreement entered into with Incyte Corporation ("Incyte") in November 2025 in exchange for the option to acquire certain rights, titles and interests related to our mutative selective JAK2V617F inhibitor program.”
FILING10-K0001193125-26-099428cik 0001678660disclosed by PRLD
“Under the settlement agreement, we paid Novartis $280.0 million as the settlement of disputed royalties on net sales of JAKAFI in the United States through December 31, 2024, and agreed to reduce by 50% the royalty rate payable by us on future net sales of JAKAFI in the United States beginning January 1, 2025.”
FILING10-K0000879169-26-000010cik 0000879169
“Acquisition-related contingent consideration, which consists of our future royalty obligations to ARIAD/Takeda, was recorded on the acquisition date, June 1, 2016, at the estimated fair value of the obligation, in accordance with the acquisition method of accounting.”
FILING10-K0000879169-26-000010cik 0000879169
Watchlist prices, news filtered to it, and its next report on your desk.
Incyte Corp has 4 disclosed suppliers and 1 disclosed customer. Each one is named in an SEC filing, either Incyte Corp’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Incyte Corp
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Services-Commercial Physical & Biological Research
Prev close 121.73 · gapped below the open, never looked back. High/low 121.73 at 3:45 pm ET, 120.16 at 10:15 am ET.
INCY (Incyte Corp) has 4 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: MGNX −3.57%, in healthcare.